ArticlePharmacological research2013

Bortezomib enhances antigen-specific cytotoxic T cell responses against immune-resistant cancer cells generated by STAT3-ablated dendritic cells.

Jee-Eun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.